These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22194967)

  • 1. Increased FAT/CD36 cycling and lipid accumulation in myotubes derived from obese type 2 diabetic patients.
    Aguer C; Foretz M; Lantier L; Hebrard S; Viollet B; Mercier J; Kitzmann M
    PLoS One; 2011; 6(12):e28981. PubMed ID: 22194967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
    Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C
    Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients.
    Aguer C; Mercier J; Man CY; Metz L; Bordenave S; Lambert K; Jean E; Lantier L; Bounoua L; Brun JF; Raynaud de Mauverger E; Andreelli F; Foretz M; Kitzmann M
    Diabetologia; 2010 Jun; 53(6):1151-63. PubMed ID: 20333349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent.
    Jeppesen J; Albers PH; Rose AJ; Birk JB; Schjerling P; Dzamko N; Steinberg GR; Kiens B
    J Lipid Res; 2011 Apr; 52(4):699-711. PubMed ID: 21297178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells.
    Egawa T; Ohno Y; Goto A; Ikuta A; Suzuki M; Ohira T; Yokoyama S; Sugiura T; Ohira Y; Yoshioka T; Goto K
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E344-54. PubMed ID: 24347059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of AMP-activated protein kinase stimulates Na+,K+-ATPase activity in skeletal muscle cells.
    Benziane B; Björnholm M; Pirkmajer S; Austin RL; Kotova O; Viollet B; Zierath JR; Chibalin AV
    J Biol Chem; 2012 Jul; 287(28):23451-63. PubMed ID: 22610379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotubes from severely obese type 2 diabetic subjects accumulate less lipids and show higher lipolytic rate than myotubes from severely obese non-diabetic subjects.
    Bakke SS; Feng YZ; Nikolić N; Kase ET; Moro C; Stensrud C; Damlien L; Ludahl MO; Sandbu R; Solheim BM; Rustan AC; Hjelmesæth J; Thoresen GH; Aas V
    PLoS One; 2015; 10(3):e0119556. PubMed ID: 25790476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.
    Chabowski A; Momken I; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
    Mol Cell Biochem; 2006 Aug; 288(1-2):201-12. PubMed ID: 16710744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes-Related Ankyrin Repeat Protein (DARP/Ankrd23) Modifies Glucose Homeostasis by Modulating AMPK Activity in Skeletal Muscle.
    Shimoda Y; Matsuo K; Kitamura Y; Ono K; Ueyama T; Matoba S; Yamada H; Wu T; Chen J; Emoto N; Ikeda K
    PLoS One; 2015; 10(9):e0138624. PubMed ID: 26398569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
    Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling.
    Luiken JJ; Coort SL; Willems J; Coumans WA; Bonen A; van der Vusse GJ; Glatz JF
    Diabetes; 2003 Jul; 52(7):1627-34. PubMed ID: 12829625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin decreases pyruvate dehydrogenase kinase 4 gene expression in obese- and diabetic-derived myotubes.
    McAinch AJ; Cameron-Smith D
    Diabetes Obes Metab; 2009 Jul; 11(7):721-8. PubMed ID: 19527483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36.
    Momken I; Chabowski A; Dirkx E; Nabben M; Jain SS; McFarlan JT; Glatz JF; Luiken JJ; Bonen A
    Biochem J; 2017 Jan; 474(1):149-162. PubMed ID: 27827305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma.
    Jeppesen J; Albers P; Luiken JJ; Glatz JF; Kiens B
    Mol Cell Biochem; 2009 Jun; 326(1-2):45-53. PubMed ID: 19142713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of phosphatidylinositol-3 kinase, AMP-activated kinase and Akt substrate-160 kDa by trans-10, cis-12 conjugated linoleic acid mediates skeletal muscle glucose uptake.
    Mohankumar SK; Taylor CG; Siemens L; Zahradka P
    J Nutr Biochem; 2013 Feb; 24(2):445-56. PubMed ID: 22704782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
    Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
    Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.
    Gaster M; Rustan AC; Aas V; Beck-Nielsen H
    Diabetes; 2004 Mar; 53(3):542-8. PubMed ID: 14988236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans.
    Steinberg GR; McAinch AJ; Chen MB; O'Brien PE; Dixon JB; Cameron-Smith D; Kemp BE
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3592-7. PubMed ID: 16822822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.
    Gaster M
    Biochem Biophys Res Commun; 2009 May; 382(4):766-70. PubMed ID: 19324004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.
    Williamson DL; Bolster DR; Kimball SR; Jefferson LS
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E80-9. PubMed ID: 16760336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.